https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, May 1, 2023


Published: Friday, April 28, 2023

OUHSC Research News – Monday, May 1, 2023

 

Notices and Reminders

Reminder: ORA would like to provide a reminder that any general or proposal-specific inquiries (what/when to route, information on the form such as participants, attachments, etc.) should be sent to your Sponsored Programs Administrator (SPA) in ORA. If unsure, visit the ORA Website to determine who that is: https://research.ouhsc.edu/research-administration/find-sponsored-program-administrators

If you are unsure of who to contact in ORA or need general triaging, please send your inquiry to hscora@OUHSC.edu. This is the only general mailbox used for triaging questions.

Please send any SoonerTrack system-specific inquiries such as workflow, stuck forms, user access, etc. to SoonerTrack Help Desk at soonertrackhelpdesk@ouhsc.edu.  And don’t forget about the SoonerTrack support site! https://research.ouhsc.edu/research-administration/soonertrack-ii-support

 

Reminder: Please be reminded that anyone who is OUHSC personnel and has effort on the grant needs to be added to the Participants grid on the SoonerTrack Request Form. All the information included in the Participants grid (e.g. participant type, name, total effort %, etc.) must match the grant. Business Managers retain primary responsibility for ensuring that all this information is correct.

 

Workshops and Seminars

The USF Summer Grant Writing Workshops

Date: Jun 5, 2023 - Jul 28, 2023

Description: The USF Summer Grant Writing Workshops program is tailored for early career grant seekers of all disciplines. At the core of this course is to advance the understanding of how to prepare a clear, comprehensive, compelling grant proposal. Participants are encouraged to identify a grant opportunity early in the program, draft a proposal, and participate in mock peer review.  

This is an 8-week workshop series. It will be offered in a virtual format. Hosted, recorded sessions will be provided to registered participants.

Registration: https://grant.catalog.instructure.com/browse/all/grants/courses/summer-grant-writing-workshops-program-2023-2501    

 

OUHSC Funding Opportunities

NEW! NIH Phase 1 COBRE (P20) call for proposals - OUHSC is now eligible to submit one new Phase 1 COBRE application for the January 30, 2024 deadline.  In order to select the most competitive PI and research theme for this COBRE application there will be an internal competition as described in the Guidelines. OUHSC internal deadline is May 12,2023.  Please see attached Call for Proposals for details and link to COBRE Guidelines.

 

New Clinical Study Opportunities

Please note this is NOT a solicitation for study subjects

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:

  • Alkermes Schizophrenia or Bipolar I Disorder Protocols ALKS 3831-A312 and ALKS 3831-A313
  • Organon Protocol: OG-8369-301 Indication: Exocrine Pancreatic Insufficiency (EPI) This is a placebo-controlled, crossover study of adult participants with Exocrine Pancreatic Insufficiency Associated with Diabetes Mellitus without a chronic pancreatitis diagnosis.
  • Organon Protocol: OG-8369-303 Indication: Exocrine Pancreatic Insufficiency (EPI) This is a comparator-controlled study of adult participants with EPI resulting from chronic pancreatitis or a partial pancreatectomy investigating a new PERT which may help reduce total pill burden for study participants.
  • Janssen_Post-ACS Survey_Protocol 70033093ACS3003
  • OG-6219-P001_Organon_Endometriosis_Global_13Mar23_GSID
  • Protocol Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to assess the Efficacy and Safety of New Formulation of Oral Cladribine compared with Placebo in Participants with Generalized Myasthenia Gravis (MyClad)
    • Target population: adult patients with MGFA Class II to IVa gMG

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • AstraZeneca is seeking applicants from final year MD and/or PhD students or Postdoctoral Researchers within three years of receiving their advanced postgraduate degree for a fully funded post-doctoral position.  Proposal in should focus on innovative technologies to improve development of novel therapeutics and treatment approaches or be an innovative idea in one of AZ’’s focus areas (cardiovascular, renal and metabolic disease, respiratory and immunology, common infectious and rare diseases).  Successful candidates will be awarded a fully funded postdoctoral position.  Submission entails completion of non-confidential application. (deadline 06/30).  
  • FMC, an agricultural sciences company, is looking for technologies and methods for the production of intermediates, 2,7-dimethylnaphthalene [582-16-1] or 2,7-dimethyl-1-bromonaphthalene [37558-62-6], for pesticidal compounds. Synthesis route should employ less than 3 chemical transformations, must be cost-effective and scalable.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 5/20)
  • Worwag Pharma is seeking novel research and technology related to the role of Vitamin D in human health and applications for prevention and treatment of deficiency.  Approaches of interest include metabolites or analogues, novel combinations, approaches with improved metabolism or mode of action, formulations to improve stability and bioavailability, improved drug delivery systems and self-diagnostic tools and digital solutions.  Out of scope: Vitamin D for use in food fortification. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 5/20)

 

 

NIH Notices 

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

Telligen Community Initiative (TCI) 2023 Request for Proposals: Strengthening Families and Communities (Social Determinants Of Health)

Description: With this Request for Proposals, TCI seeks to emphasize the integration of childhood, family, and community health in new ways for our foundation. TCI wants to resource efforts that advance optimal physical, mental, and social health and well-being for families, children and youth in the four states TCI supports. We will prioritize reaching caregivers of color and families with limited financial resources – in rural, frontier, or urban settings. Programs supported can be advancing established evidence-based programs or the refinement of emerging and promising community-based practices. Below represents the targeted areas TCI wants to advance with our philanthropy in this RFP within the social determinants of health. It is also accompanied by illustrative examples of what programmatic efforts and success indicators could be built around. The potential focus or indicators of success are not prescribed or limited to what could be requested for TCI consideration by an applicant. They are just examples meant to stimulate thought and meet your community needs and work where our funding could be most impactful to your plan. That said, the overall part of the social determinants of health we want to position our funding around is strengthening families and efforts that could build family and community resiliency and enhancement of protective factors. These are the only funding themes we intend to support with TCI grant awards. 

Application Deadline: June 16, 2023

Link to Full Announcement: https://telligenci.org/content/uploads/2022/12/2023-RFP-Strengthening-Families-and-Communities-6-16-2023-Deadline.pdf

 

Cystic Fibrosis (CF) Foundation: PTAC Collaborative Research Grant

Description: The PTAC Collaborative Research Grant supports integrated, multi-investigator collaborative research programs that will advance the priorities of the PTAC Initiative.  A Collaborative Research Grant proposal must have at least two, and may include up to four, related research projects that share a well-defined theme and overall objective. This program has a budget cap of $1M DC plus 12% IDC.  Applicants must speak with CFF program staff prior to submitting a proposal. For questions please contact John Sheridan (jsheridan@cff.org).

Application Deadline: Applications must be submitted online at awards.cff.org by July 13, 2023.

Link to Full Announcement: https://www.cff.org/researchers/path-cure-collaborative-research-grant

 

Cystic Fibrosis (CF) Foundation: Biological Basis for CF-Related Diabetes Program

Description: The PTAC Collaborative Research Grant supports integrated, multi-investigator collaborative research programs that will advance the priorities of the PTAC Initiative.  A Collaborative Research Grant proposal must have at least two, and may include up to four, related research projects that share a well-defined theme and overall objective. This program has a budget cap of $1M DC plus 12% IDC.  Applicants must speak with CFF program staff prior to submitting a proposal. For questions please contact John Sheridan (jsheridan@cff.org).

Application Deadline: Applications must be submitted online at awards.cff.org by July 13, 2023. 

Link to Full Announcement: https://www.cff.org/researchers/biological-basis-cf-related-diabetes-program

 

The Robert Wood Johnson Foundation: Health Equity Scholars for Action (HES4A)

Description: Health Equity Scholars for Action (HES4A) supports the career development and academic advancement of historically underrepresented researchers conducting health equity research.

HES4A scholars receive:

  • Funding for research on potential solutions to improve health, equity, and well-being for all;
  • Coaching and mentorship to help develop and strengthen technical skills and explore career opportunities; and,
  • A professional network of community partners, researchers, public health practitioners, and funders committed to advancing the health equity research field.

LOI Deadline: May 31, 2023 

Link to Full Announcement: https://www.rwjf.org/en/grants/active-funding-opportunities/2023/health-equity-scholars-for-action.html  

 

The Chan Zuckerberg Initiative (CZI)

Description: The Chan Zuckerberg Initiative (CZI) seeks to support two-year collaborative research projects focused on measuring metabolism across organelles and cells. The ability to characterize temporally and spatially the broad molecular profiles, heterogeneity, and phenotypic diversity of organelles and cells and how they interact within and as systems are key to measuring human biology, understanding disease mechanisms, and finding treatments and cures. This Request for Applications (RFA) aims to accelerate innovative discoveries in metabolism and metabolic physiology in health and disease.

Application Deadline: June 1, 2023

Link to Full Announcement: https://chanzuckerberg.com/rfa/measuring-metabolism-across-scales/

 

DoD Lung Cancer Research Program (LCRP)

  • Idea Development Award (IDA)
  • Translational Research Award (TRA)

Pre-Application (Preproposal): May 10, 2023
Application: August 3, 2023

  • Patient-Centered Outcomes and Survivorship Award (PCOSA)

Pre-Application (Letter of Intent): July 20, 2023
Application: August 10, 2023

Link to Full Announcement: https://cdmrp.health.mil/funding/lcrp

 

Cystic Fibrosis (CF) Foundation 

Application Deadline: May 11, 2023

 

CF Foundation NIH K-Boost Award

Description: This award is designed to provide a $50,000 per year supplement to an NIH K-award that has a CF focus.

Application Deadline: Rolling applications must be submitted online at awards.cff.org.

For questions, please contact Elizabeth Yu (eyu@cff.org). 

Link to Full Announcement: https://www.cff.org/researchers/cf-foundation-nih-k-boost-award                                                                 

 

CF Foundation/NIH K-Unfunded Award

Description: This award is designed to provide support for investigators with meritorious NIH K applications that were not selected for funding as they revise and resubmit.

Application Deadline: Rolling applications must be submitted online at awards.cff.org.

For questions, please contact Elizabeth Yu (eyu@cff.org). 

Link to Full Announcement: https://www.cff.org/researchers/cf-foundationnih-k-unfunded-award

 

CF Research Additional Mentoring Program (RAMP)

Description: The RAMP Award is designed to enable promising early-career physician scientists seeking additional research mentoring outside of their home academic institutions to enhance their clinical or translational research proficiency and support their development of the necessary clinical research capabilities to become independent investigators.

Application Deadline: Applications must be submitted online at awards.cff.org by May 23, 2023.

For questions, please contact Elizabeth Yu (eyu@cff.org). 

Link to Full Announcement: https://www.cff.org/researchers/research-additional-mentoring-program-award

 

The Lung Cancer Research Foundation (LCRF) – Daiichi Sankyo – AstraZeneca Research Grant on Antibody Drug Conjugates

Description: LCRF is pleased to announce a collaboration with Daiichi Sankyo and AstraZeneca to fund up to three research grants focused on antibody drug conjugates (ADCs) to improve outcomes for people with lung cancer. This competitive funding mechanism will provide up to $270,000 in funding over a two-year period.

The LCRF - Daiichi Sankyo - AstraZeneca Research Grant on Antibody Drug Conjugates will develop further understanding of the mechanism of action and biomarkers for TROP2 directed ADCs in lung cancer and HER2 directed ADCs in HER2 mutant NSCLC and primary and acquired resistance to TROP2 directed and HER2 directed ADCs.

Application Deadline: May 31, 2023

Link to Full Announcement: Complete details including eligibility criteria and application instructions may be found on the LCRF website.

 

 Robert A. Winn Career Development Award (Winn CDA)

Description: The goal of the Robert A. Winn Career Development Award (Winn CDA) is to increase the diversity of patients enrolled in clinical trials, and ultimately to enhance the development of therapeutics for all populations. The program collaborates with communities to facilitate an approach to clinical and translational research that is community-informed, designed, and conducted. It provides emerging investigators the sponsorship, support, and tools they need to conduct clinical trials that will yield new treatments effective in all populations.

Application Deadline: May 12, 2023

Link to Full Announcement: https://diversityinclinicaltrials.org/application-information . Please see the attached flyers.

 

DoD Ovarian Cancer Research Program (OCRP)

  • Clinical Translational Research Award
  • Clinical Trial Award
  • Ovarian Cancer Clinical Trial Academy - Leadership Award

Pre-Application: May 26, 2023

Application: July 21, 2023

Link to Full Announcement: https://cdmrp.health.mil/funding/ocrp

 

DoD Epilepsy Research Program (ERP)

Pre-Application (Letter of Intent): May 19, 2023

Application: June 23, 2023

Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495101

 

The International Center for Responsible Gaming - REQUEST FOR APPLICATIONS ON RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS

Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the effectiveness of “pre-commitment,” a prevention strategy that encourages gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.

Application Deadline: May 15, 2023

Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding

Documents to download